These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28572223)

  • 1. Developments in therapy with monoclonal antibodies and related proteins.
    Shepard HM; Phillips GL; D Thanos C; Feldmann M
    Clin Med (Lond); 2017 Jun; 17(3):220-232. PubMed ID: 28572223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic monoclonal antibodies in ophthalmology.
    Rodrigues EB; Farah ME; Maia M; Penha FM; Regatieri C; Melo GB; Pinheiro MM; Zanetti CR
    Prog Retin Eye Res; 2009 Mar; 28(2):117-44. PubMed ID: 19114125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology and therapeutic applications of monoclonal antibodies.
    Castelli MS; McGonigle P; Hornby PJ
    Pharmacol Res Perspect; 2019 Dec; 7(6):e00535. PubMed ID: 31859459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know.
    Silberstein S; Lenz R; Xu C
    Headache; 2015 Sep; 55(8):1171-82. PubMed ID: 26316307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New monoclonal antibodies in renal transplantation.
    Vincenti F
    Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-PET: a navigator in monoclonal antibody development and applications.
    van Dongen GA; Visser GW; Lub-de Hooge MN; de Vries EG; Perk LR
    Oncologist; 2007 Dec; 12(12):1379-89. PubMed ID: 18165614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized nonclinical safety assessment strategies supporting clinical development of therapeutic monoclonal antibodies targeting inflammatory diseases.
    Brennan FR; Cauvin A; Tibbitts J; Wolfreys A
    Drug Dev Res; 2014 May; 75(3):115-61. PubMed ID: 24782266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.
    Dostalek M; Gardner I; Gurbaxani BM; Rose RH; Chetty M
    Clin Pharmacokinet; 2013 Feb; 52(2):83-124. PubMed ID: 23299465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamentals of antibody-related therapy and diagnostics.
    Albrecht H; Radosevich JA; Babich M
    Drugs Today (Barc); 2009 Mar; 45(3):199-211. PubMed ID: 19436842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Strategy of Monoclonal Antibody: Development, Cloning, Formulation and Drug Delivery.
    Kaliyaperumal R; Ranganathan S; Krishnamoorthy M; Mohan VK; Balaraman S; Rajapandian G; Sathiyasundar R; Ravindran S
    Recent Adv Drug Deliv Formul; 2023; 17(4):264-285. PubMed ID: 37909435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The next generation of antibody-drug conjugates comes of age.
    Beck A; Haeuw JF; Wurch T; Goetsch L; Bailly C; Corvaïa N
    Discov Med; 2010 Oct; 10(53):329-39. PubMed ID: 21034674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies.
    Johnson DE
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30469350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases.
    Flego M; Ascione A; Cianfriglia M; Vella S
    BMC Med; 2013 Jan; 11():4. PubMed ID: 23289632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody-based therapeutics for leukemia.
    Li Y; Zhu Z
    Expert Opin Biol Ther; 2007 Mar; 7(3):319-30. PubMed ID: 17309324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.
    Teillaud JL
    Expert Opin Biol Ther; 2005 Sep; 5 Suppl 1():S15-27. PubMed ID: 16187937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of head-to-head trials of approved monoclonal antibodies used in cancer: an overview of the clinical trials agenda.
    Luo J; Nishikawa G; Prasad V
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2303-2311. PubMed ID: 31396700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metrics for antibody therapeutics development.
    Reichert JM
    MAbs; 2010; 2(6):695-700. PubMed ID: 20930555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical pharmacology of therapeutic monoclonal antibodies in the treatment of malignancy; have the magic bullets arrived?
    Newsome BW; Ernstoff MS
    Br J Clin Pharmacol; 2008 Jul; 66(1):6-19. PubMed ID: 18503606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic antibodies against cancer.
    Adler MJ; Dimitrov DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.